Ophir is pleased to announce the appointment of Dr. Adel Chaouch as an independent non-executive Director to the Company’s Board with immediate effect.
This announcement sets out the disclosure required by section 430(2B) of the Companies Act 2006 in relation to the departure of Nicholas Cooper from Ophir Energy plc (the “Company”).
Ophir is pleased to announce the appointment of Mr David Davies and Dr Carl Trowell as independent non-executive Directors to the Company’s Board with immediate effect.
Ophir Energy plc (“Ophir” or “the Company”) announces that it has appointed, Dr John Bell to the position of Director – Asia and Dr Oliver Quinn to the position of Director – Africa and Global New Ventures.
In accordance with Rule 9.6.11(3) of the Listing Rules, the Board of Directors of the Company announces that the following changes have been made to the membership of its Board committees, with immediate effect:
Following today's vote by the Company’s shareholders in favour of the proposed acquisition by the Company of the entire issued and to be issued share capital of Salamander Energy plc (“Salamander”) (the “Transaction”), to be effected by means of a court-sanctioned scheme of arrangement under Part 26 of the Companies Act 2006, the Board of the Company has formally approved the appointment of Dr Carol Bell, currently a Non-Executive director of Salamander, as a Non-Executive Director of the Company subject to and with effect from the effective date of the Transaction. The effective date of the Transaction is currently expected to be 2 March 2015.
As part of a reorganisation across all levels of the Company designed to reduce costs, and adjust to the future needs of the business, the Board of Ophir is to restructure and streamline the senior management team. The restructuring will result in a smaller Board with the number of Executive Directors reducing from three to two and Non-Executive Directors reducing from six to five.